Venus Remedies Patents – Insights & Stats

Venus Remedies has a total of 103 patents globally, out of which 54 have been granted. Of these 103 patents, more than 25% patents are active. India is where Venus Remedies has filed the maximum number of patents, followed by USA and Korea (South). Parallelly, India seems to be the main focused R&D center and also is the origin country of Venus Remedies.

Venus Remedies was founded in 1989. Venus Remedies is a pharmaceutical manufacturing unit. The Company manufactures products such as I.V. fluids, antibiotics, anti-histamines, third and fourth generation Cephalosporins and Oncology drugs. As of June 2022, Venus Remedies has a market cap of 281 Crore.

Read about some of the most popular patents of Venus Remedies which have been covered by us in this article and also you can find Venus Remedies patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Venus Remedies patent portfolio.

How many patents does the CEO of Venus Remedies have?

The CEO Pawan Chaudhary has 0 patents.

How many patents does Venus Remedies have?

Venus Remedies has a total of 103 patents globally. These patents belong to 14 unique patent families. Out of 103 patents, 26 patents are active.

How Many Patents did Venus Remedies File Every Year?

Venus Remedies Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantVenus Remedies Applications FiledVenus Remedies Patents Granted
20111110
201214
201312
20148
20152
20171
20181

How many Venus Remedies patents are Alive/Dead?

Worldwide Patents

Venus Remedies Patents Portfolio

How Many Patents did Venus Remedies File in Different Countries?

Venus Remedies Worldwide Patents

Countries in which Venus Remedies Filed Patents

CountryPatents
India10
United States Of America8
Korea (South)8
Japan6
Europe6
Australia6
South Africa5
Brazil5
China5
Mexico5
Germany4
Spain3
Canada3
Portugal3
New Zealand3
Ukraine2
Poland2
Austria2
Russia2
Slovenia2
Croatia1
Denmark1
Singapore1
Albania1
Cyprus1
Serbia1

Where are Research Centers of Venus Remedies Patents Located?

Research Centers of Venus Remedies Patents

10 Best Venus Remedies Patents

US8778873B2 is the most popular patent in the Venus Remedies portfolio. It has received 23 citations so far from companies like Neogen Nv, Merck Sharp & Dohme Corp and Cubist Pharmaceuticals.

Below is the list of 10 most cited patents of Venus Remedies:

Publication NumberCitation Count
US8778873B223
WO2006064516A114
JP2008540515A9
RU2397768C26
CN101080230A3
KR1020070067189A3
US20130295052A12
CN101060846A2
AU2006245302A12
US8273732B21

What Percentage of Venus Remedies US Patent Applications were Granted?

Venus Remedies (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 80.0%.

Below are the key stats of Venus Remedies patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Venus Remedies?

Law FirmTotal ApplicationsSuccess Rate
Hultquist Ip3100.00%
Blank Rome Llp10.00%

EXCLUSIVE INSIGHTS COMING SOON!

What are Venus Remedies key innovation segments?

What Technologies are Covered by Cognite?

The chart below distributes patents filed by Venus Remedies in different countries on the basis of the technology protected in patents. It also represents the markets where Venus Remedies thinks it’s important to protect particular technology inventions.

R&D Focus: How has Venus Remedies search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Venus Remedies?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.